Literature DB >> 30825709

Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.

Macarena Martínez-Bailén1, Ana T Carmona2, Athéna C Patterson-Orazem3, Raquel L Lieberman3, Daisuke Ide4, Moemi Kubo4, Atsushi Kato4, Inmaculada Robina1, Antonio J Moreno-Vargas5.   

Abstract

The synthesis of a library of pyrrolidine-aryltriazole hybrids through CuAAC between two epimeric dihydroxylated azidomethylpyrrolidines and differently substituted phenylacetylenes is reported. The evaluation of the new compounds as inhibitors of lysosomal β-glucocerebrosidase showed the importance of the substitution pattern of the phenyl moiety in the inhibition. Crystallization and docking studies revealed key interactions of the pyrrolidine motif with aminoacid residues of the catalytic site while the aryltriazole moiety extended along a hydrophobic surface groove. Some of these compounds were able to increase the enzyme activity in Gaucher patient fibroblasts, acting as a new type of chemical chaperone for Gaucher disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chaperones; Click chemistry; Iminosugars; Protein crystallization; Pyrrolidines; Triazoles; β-glucocerebrosidase inhibitors

Year:  2019        PMID: 30825709     DOI: 10.1016/j.bioorg.2019.02.025

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  5 in total

Review 1.  Glucocerebrosidase as a therapeutic target for Parkinson's disease.

Authors:  Yu Chen; Richard Sam; Pankaj Sharma; Lu Chen; Jenny Do; Ellen Sidransky
Journal:  Expert Opin Ther Targets       Date:  2020-02-27       Impact factor: 6.902

2.  Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents.

Authors:  Rhianna J Rowland; Yurong Chen; Imogen Breen; Liang Wu; Wendy A Offen; Thomas J Beenakker; Qin Su; Adrianus M C H van den Nieuwendijk; Johannes M F G Aerts; Marta Artola; Herman S Overkleeft; Gideon J Davies
Journal:  Chemistry       Date:  2021-10-29       Impact factor: 5.020

3.  Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.

Authors:  Jorge Franco; Francesco Piacente; Melanie Walter; Simone Fratta; Moustafa Ghanem; Andrea Benzi; Irene Caffa; Alexander V Kurkin; Andrea Altieri; Patrick Herr; Macarena Martínez-Bailén; Inmaculada Robina; Santina Bruzzone; Alessio Nencioni; Alberto Del Rio
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-12

Review 4.  Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance.

Authors:  Yali Wang; Jian Xiao; Aiguo Meng; Chunyan Liu
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

Review 5.  GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.

Authors:  Macarena Martínez-Bailén; Francesca Clemente; Camilla Matassini; Francesca Cardona
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.